Gary Charbonneau joined Sarepta in April 2018 as Senior Vice President, Regulatory Affairs, overseeing all aspects of our regulatory affairs organization including development strategy and global regulatory operations. Sarepta Therapeutics is a precision genetic medicine company with programs that include RNA, Gene Therapy, and Editing modalities.
Mr. Charbonneau brings over 25 years of industry experience to Sarepta, having spent much of his career in Regulatory Affairs and Quality Assurance. Prior to joining Sarepta, he served as Senior Vice President of Global Regulatory Affairs at Graybug Vision in Redwood City, CA.
From September 2005 to June 2016, Mr. Charbonneau served as Vice President of Regulatory Affairs at Allergan, where he held several leadership roles within the organization during his 11-year career with the global pharmaceutical company. During his tenure at Allergan, Mr. Charbonneau was integral in building the Global Regulatory Affairs function, in addition to working within various therapeutic areas including ophthalmology, urology, dermatology, and neurology. Mr. Charbonneau has also spent time at Amgen, Roche Bioscience, and Novo Nordisk in various roles during the course of his career in the life science and pharmaceutical industries. Mr. Charbonneau received his Bachelors of Science degree in Biological Science from California Polytechnic State University, San Luis Obispo and his Masters in Regulatory Science from the University of Southern California.